Stock Taper
CeriBell, Inc. develops AI-powered point-of-care EEG technology, including the Ceribell System and disposable headbands, to improve detection and treatment of neurological conditions in acute care settings.

Ceribell System is a portable, AI-powered EEG platform for rapid diagnosis and monitoring of neurological conditions like seizures and stroke in acute care, enabling quick assessment and recently receiving FDA Breakthrough Designation.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $17.02M | $18.78M ▲ | $20.19M ▲ | $21.24M ▲ |
![]() | Subscription | $5.57M | $6M ▲ | $6.3M ▲ | $6.86M ▲ |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
BFLY | $8.43 | COMPARE |
VREX | $18.50 | COMPARE |
AUTL | $2.34 | COMPARE |
KIDS | $23.65 | COMPARE |
TMCI | $4.65 | COMPARE |
LAB | $0.64 | COMPARE |
QSI | $0.78 | COMPARE |